Comparison of cutaneous adverse events between second-generation tyrosine kinase inhibitors and imatinib for chronic myeloid leukemia: a systematic review and meta-analysis.

Cha, Seung-Hyeon; Kim, Kyungim; Song, Yun-Kyoung

Cha, Seung-Hyeon; Kim, Kyungim; Song, Yun-Kyoung.

Affiliation

Cha SH; College of Pharmacy, Daegu Catholic University, Gyeongbuk, Republic of Korea.
Kim K; College of Pharmacy, Korea University, Sejong, Republic of Korea.
Song YK; College of Pharmacy, Daegu Catholic University, Gyeongbuk, Republic of Korea.

Acta Oncol ; 62(12): 1767-1774, 2023 Dec.

Article in En | MEDLINE | ID: mdl-37787749

Subject(s)

Antineoplastic Agents; Exanthema; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Humans; Imatinib Mesylate/adverse effects; Dasatinib/therapeutic use; Protein Kinase Inhibitors/adverse effects; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Pyrimidines/adverse effects; Pruritus/chemically induced; Pruritus/epidemiology; Pruritus/drug therapy; Exanthema/chemically induced; Antineoplastic Agents/adverse effects

Key words

adverse events; chronic myeloid leukemia; cutaneous; meta-analysis; tyrosine kinase inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Exanthema / Antineoplastic Agents Type of study: Etiology_studies / Systematic_reviews Limits: Humans Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google